Ignite Creation Date:
2025-12-25 @ 3:22 AM
Ignite Modification Date:
2025-12-26 @ 2:00 AM
Study NCT ID:
NCT00462605
Status:
COMPLETED
Last Update Posted:
2017-07-18
First Post:
2007-04-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-04
Start Date Type:
None
Primary Completion Date:
2011-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-04-18
First Submit QC Date:
None
Study First Post Date:
2007-04-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-06
Results First Submit QC Date:
None
Results First Post Date:
2017-04-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-16
Last Update Post Date:
2017-07-18
Last Update Post Date Type:
ACTUAL